These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 20009237)
1. Genetic variation in the G720/G30 gene locus (DAOA) influences the occurrence of psychotic symptoms in patients with Alzheimer's disease. Di Maria E; Bonvicini C; Bonomini C; Alberici A; Zanetti O; Gennarelli M J Alzheimers Dis; 2009; 18(4):953-60. PubMed ID: 20009237 [TBL] [Abstract][Full Text] [Related]
2. Psychotic symptoms in Alzheimer's disease are not influenced by polymorphic variation at the dopamine receptor DRD3 gene. Craig D; Hart DJ; Carson R; McIlroy SP; Passmore AP Neurosci Lett; 2004 Sep; 368(1):33-6. PubMed ID: 15342129 [TBL] [Abstract][Full Text] [Related]
3. No association between neuregulin 1 and psychotic symptoms in Alzheimer's disease patients. Middle F; Pritchard AL; Handoko H; Haque S; Holder R; Bentham P; Lendon CL J Alzheimers Dis; 2010; 20(2):561-7. PubMed ID: 20182055 [TBL] [Abstract][Full Text] [Related]
4. Role of 5HT 2A and 5HT 2C polymorphisms in behavioural and psychological symptoms of Alzheimer's disease. Pritchard AL; Harris J; Pritchard CW; Coates J; Haque S; Holder R; Bentham P; Lendon CL Neurobiol Aging; 2008 Mar; 29(3):341-7. PubMed ID: 17098333 [TBL] [Abstract][Full Text] [Related]
5. The interleukin 1beta gene promoter polymorphism (-511) acts as a risk factor for psychosis in Alzheimer's dementia. Craig D; Hart DJ; McCool K; McIlroy SP; Passmore AP Ann Neurol; 2004 Jul; 56(1):121-4. PubMed ID: 15236409 [TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype studies in bipolar disorder showing association between the DAOA/G30 locus and persecutory delusions: a first step toward a molecular genetic classification of psychiatric phenotypes. Schulze TG; Ohlraun S; Czerski PM; Schumacher J; Kassem L; Deschner M; Gross M; Tullius M; Heidmann V; Kovalenko S; Jamra RA; Becker T; Leszczynska-Rodziewicz A; Hauser J; Illig T; Klopp N; Wellek S; Cichon S; Henn FA; McMahon FJ; Maier W; Propping P; Nöthen MM; Rietschel M Am J Psychiatry; 2005 Nov; 162(11):2101-8. PubMed ID: 16263850 [TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the 13q33.2 gene G72/G30 are associated with childhood-onset schizophrenia and psychosis not otherwise specified. Addington AM; Gornick M; Sporn AL; Gogtay N; Greenstein D; Lenane M; Gochman P; Baker N; Balkissoon R; Vakkalanka RK; Weinberger DR; Straub RE; Rapoport JL Biol Psychiatry; 2004 May; 55(10):976-80. PubMed ID: 15121480 [TBL] [Abstract][Full Text] [Related]
8. Psychotic symptoms in Alzheimer's disease and 5-HTTLPR polymorphism of the serotonin transporter gene: evidence for an association. Quaranta D; Bizzarro A; Marra C; Vita MG; Seripa D; Pilotto A; Sebastiani V; Mecocci P; Masullo C J Alzheimers Dis; 2009; 16(1):173-80. PubMed ID: 19158433 [TBL] [Abstract][Full Text] [Related]
9. Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation. Holmes C; Smith H; Ganderton R; Arranz M; Collier D; Powell J; Lovestone S J Neurol Neurosurg Psychiatry; 2001 Dec; 71(6):777-9. PubMed ID: 11723200 [TBL] [Abstract][Full Text] [Related]
10. Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease. Assal F; Alarcón M; Solomon EC; Masterman D; Geschwind DH; Cummings JL Arch Neurol; 2004 Aug; 61(8):1249-53. PubMed ID: 15313842 [TBL] [Abstract][Full Text] [Related]
11. Haplotypes in cathechol-O-methyltransferase gene confer increased risk for psychosis in Alzheimer disease. Borroni B; Grassi M; Costanzi C; Zanetti M; Archetti S; Franzoni S; Caimi L; Padovani A Neurobiol Aging; 2007 Aug; 28(8):1231-8. PubMed ID: 16837108 [TBL] [Abstract][Full Text] [Related]
12. G72 gene is associated with susceptibility to methamphetamine psychosis. Kotaka T; Ujike H; Okahisa Y; Takaki M; Nakata K; Kodama M; Inada T; Yamada M; Uchimura N; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(6):1046-9. PubMed ID: 19482054 [TBL] [Abstract][Full Text] [Related]
13. [Neuropsychiatric features in Dementia with Lewy bodies and Alzheimer's disease]. Hirono N; Mori E; Imamura T; Shimomura T; Hashimoto M No To Shinkei; 1998 Jan; 50(1):45-9. PubMed ID: 9493198 [TBL] [Abstract][Full Text] [Related]
14. Delusion symptoms and response to antipsychotic treatment are associated with the 5-HT2A receptor polymorphism (102T/C) in Alzheimer's disease: a 3-year follow-up longitudinal study. Angelucci F; Bernardini S; Gravina P; Bellincampi L; Trequattrini A; Di Iulio F; Vanni D; Federici G; Caltagirone C; Bossù P; Spalletta G J Alzheimers Dis; 2009; 17(1):203-11. PubMed ID: 19494443 [TBL] [Abstract][Full Text] [Related]
15. 5-HT2A T102C receptor polymorphism and neuropsychiatric symptoms in Alzheimer's disease. Lam LC; Tang NL; Ma SL; Zhang W; Chiu HF Int J Geriatr Psychiatry; 2004 Jun; 19(6):523-6. PubMed ID: 15211529 [TBL] [Abstract][Full Text] [Related]
16. Significant support for DAO as a schizophrenia susceptibility locus: examination of five genes putatively associated with schizophrenia. Wood LS; Pickering EH; Dechairo BM Biol Psychiatry; 2007 May; 61(10):1195-9. PubMed ID: 17055463 [TBL] [Abstract][Full Text] [Related]
17. [Psychotic symptoms and Alzheimer's disease]. Alberca R; Gil-Néciga E; Salas D; Pérez JA; Lozano P Neurologia; 2000 Jan; 15(1):8-14. PubMed ID: 10730061 [TBL] [Abstract][Full Text] [Related]
18. Genetic variation in N-methyl-D-aspartate receptor subunit NR3A but not NR3B influences susceptibility to Alzheimer's disease. Liu HP; Lin WY; Liu SH; Wang WF; Tsai CH; Wu BT; Wang CK; Tsai FJ Dement Geriatr Cogn Disord; 2009; 28(6):521-7. PubMed ID: 20016182 [TBL] [Abstract][Full Text] [Related]
19. The PPAR-alpha gene in Alzheimer's disease: lack of replication of earlier association. Sjölander A; Minthon L; Bogdanovic N; Wallin A; Zetterberg H; Blennow K Neurobiol Aging; 2009 Apr; 30(4):666-8. PubMed ID: 17850927 [TBL] [Abstract][Full Text] [Related]
20. Relationship of the Ubiquilin 1 gene with Alzheimer's and Parkinson's disease and cognitive function. Arias-Vásquez A; de Lau L; Pardo L; Liu F; Feng BJ; Bertoli-Avella A; Isaacs A; Aulchenko Y; Hofman A; Oostra B; Breteler M; van Duijn C Neurosci Lett; 2007 Aug; 424(1):1-5. PubMed ID: 17709205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]